Table 1. Patients characteristics.

	Treatment
	(n = 7)
Age in years	20 (7.8)
12–21 years	3 (43%)
22–35 years	4 (57%)
Men	4 (57%)
Ethnic origin
White	6 (86%)
Non-white	1 (14%)
Body-mass index	22.4 (2.2)
Days since diagnosis	62.7 (24.4)
Baseline 2-h C-peptide area under the curve (pmol/ml)	0.764 (0.219)
Anti-Neu5Gc IgG (ng/μl)*
Baseline	5.4 (2.3)
Month 1	212.4 (368.9)

^*Measure by EIA assay [7].